Page 207 - Read Online

Suominen et al. J Cancer Metastasis Treat 2019;5:14 I http://dx.doi.org/10.20517/2394-4722.2018.64 Page 13 of 13

29. Heymann D. Bone cancer: primary bone cancers and bone metastases. 2th ed. Amsterdam: Elsevier/Academic Press; 2015. p. 486.
30. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601.
31. Haider MT, Holen I, Dear TN, Hunter K, Brown HK. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications
for breast cancer bone metastasis. Bone 2014;66:240-50.
32. Lv Y, Wang G, Xu W, Tao P, Lv X, et al. Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7
cells treated with receptor-activated nuclear κB ligand. Exp Ther Med 2015;9:143-6.